GADD45B and hepatocellular carcinoma: The expression of GADD45B is consistently shown to be downregulated in most of the HCC patient samples studied in TCGA (Supplementary Figure S6C) and GSE14520 (Supplementary Figure S6D) and the induction of GADD45B expression contributed to sorafenib-induced apoptosis in HCC cells.21